NYSE
PG
Last Price
US $146.64
KEY FIGURES
MKT CAP
$346.8B
EPS
TTM
$6.90
PEG
TTM
2.65x
P/E
TTM
21.31x
P/S
TTM
4.12x
YIELD
2.86%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
31.32%
Return on equity
ROIC: 15.53%
Valuation History
21.3X
Price to Earnings
EV/EBITDA: 14.9X
Cash flow
Profit margin
3.50%
(FY vs FY)
EBITDA Y/Y
4.37%
(FY vs FY)
Cash flow Y/Y
-0.40%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $146.64
-60.39%
Default assumptions
EBITDA Multiple
Fair Value
Market $146.64
-58.69%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
The Procter & Gamble Company cash flow to debt ratio of 50.24% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
The Procter & Gamble Company's free cash flow has decreased -15.01% from $16.52G last year to $14.04G, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
The Procter & Gamble Company's debt to equity ratio is 0.68, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
The Procter & Gamble Company's debt has increased relative to shareholder equity from 0.66 last year to 0.68 today, signaling weakened financials
Financial stability - Net debt/EBITDA.
The Procter & Gamble Company has a net debt to EBITDA ratio of 1.08x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
The Procter & Gamble Company's interest coverage ratio of 48.92 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
The Procter & Gamble Company's profit margin has increased (8.54%) in the last year from 17.70% to 19.22%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
The Procter & Gamble Company's short-term liabilities of $36.06G exceed its short-term assets of $25.39G, signaling financial risk
Increasing performance - ROA.
The Procter & Gamble Company's return on assets of 12.98% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
The Procter & Gamble Company's return on equity of 31.32%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
The Procter & Gamble Company's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
The Procter & Gamble Company had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
The Procter & Gamble Company has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
The Procter & Gamble Company has a free cash flow yield of 4.05%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
The Procter & Gamble Company's yearly earnings has increased 7.36% since last year from $14.88G to $15.97G, signaling increasing performance
Increasing performance - Healthy revenue growth.
The Procter & Gamble Company's yearly revenue has increased 0.29% since last year from $84.04G to $84.28G, signaling increasing performance
Increasing performance - ROIC.
ROIC 15.53% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
The Procter & Gamble Company's 3-year revenue CAGR of 1.67% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
The Procter & Gamble Company had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
The Procter & Gamble Company had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
The Procter & Gamble Company is overvalued relative to its fair value price of 58.08 based on Discounted Cash Flow model
Undervalued - Earnings yield.
The Procter & Gamble Company has an earnings yield of 4.63%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
The Procter & Gamble Company is overvalued relative to its fair value price of 60.58 based on EBITDA multiple model
Undervalued - EV/EBITDA.
The Procter & Gamble Company has an EV/EBITDA ratio of 14.93x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
The Procter & Gamble Company has a PEG-ratio over 1 which is considered overvalued
Overvalued - P/B ratio.
The Procter & Gamble Company has a price-to-book ratio of 6.60x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Undervalued - P/S ratio.
The Procter & Gamble Company has a price-to-sales ratio of 4.00x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue